British Pharmacopoeia (BP) 2024: Comprehensive Standards for Pharmaceutical Products in the UKThe BP 2024 Single-user Online SubscriptionThe Single-user Online Subscription includes:
- A single-user online licence* valid from 1 August 2023 to 31 March 2025
The British Pharmacopoeia (BP) is an annually updated, authoritative collection of standards governing pharmaceutical substances and medicinal products in the UK. With approximately 4,000 legally enforced monographs outlined by the Human Medicines Regulations 2012, compliance is mandatory for medicinal products and active pharmaceutical ingredients distributed in the UK.
Key Features of BP 2024:
Legal Effectiveness: The BP 2024, effective from January 1, 2024, supersedes the BP 2023. It incorporates new monographs from both the BP and the European Pharmacopoeia (Ph. Eur.) alongside a substantial number of revised monographs.
- 27 new BP monographs
- 17 new Ph. Eur. monographs
- 93 amended BP monographs
- Inclusion of all monographs from Ph. Eur. 11th edition
- Ph. Eur. supplements 11.4 to 11.6 included as in-year online and download product updates
- European and Global Relevance: The BP includes all monographs and requirements of the Ph. Eur., positioning it as a comprehensive set of standards applicable not only in the UK but across Europe and beyond.
Enhancements for BP 2024:
User Experience: The BP website is undergoing updates for an improved user experience.
Design and Navigation: A fresh and user-friendly design, coupled with improved navigation, ensures a seamless browsing experience.
Search Functionality: An advanced in-publication search feature and enhanced layout make it easier to find the necessary monographs.
Timeline and Changes Tracking: A revamped timeline and tracked changes feature allow users to trace the evolution of monographs over time.
Other formats are available to ensure users get the best value access to the information they need
*Note: Single-user licenses are granted to one designated holder. Multi-user licenses are available.